GE HealthCare Technologies Inc. (NASDAQ:GEHC) to Issue Quarterly Dividend of $0.04

GE HealthCare Technologies Inc. (NASDAQ:GEHC) announced a quarterly dividend on Thursday, March 27th, RTT News reports. Stockholders of record on Friday, April 25th will be given a dividend of 0.035 per share on Thursday, May 15th. This represents a $0.14 annualized dividend and a dividend yield of 0.17%.

GE HealthCare Technologies has a dividend payout ratio of 2.7% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect GE HealthCare Technologies to earn $5.20 per share next year, which means the company should continue to be able to cover its $0.14 annual dividend with an expected future payout ratio of 2.7%.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $81.66 on Friday. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. GE HealthCare Technologies has a 12 month low of $74.51 and a 12 month high of $94.80. The company has a market capitalization of $37.34 billion, a price-to-earnings ratio of 18.86, a PEG ratio of 3.19 and a beta of 1.13. The firm’s 50-day moving average is $86.79 and its 200 day moving average is $85.90.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.33 billion. Research analysts predict that GE HealthCare Technologies will post 4.68 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on GEHC. The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. Citigroup lifted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, February 13th. Wells Fargo & Company upped their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research note on Friday, February 14th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and lifted their price target for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $98.75.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.